candesartan cilexetil has been researched along with Hypertrophy, Right Ventricular in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamane, T | 1 |
| Fujii, Y | 1 |
| Orito, K | 1 |
| Osamura, K | 1 |
| Kanai, T | 1 |
| Wakao, Y | 1 |
1 trial available for candesartan cilexetil and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Comparison of the effects of candesartan cilexetil and enalapril maleate on right ventricular myocardial remodeling in dogs with experimentally induced pulmonary stenosis.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Constriction, Pathologic; Dog | 2008 |